Stanford Cancer Institute Innovation Awards
Internal — Stanford University only
Stanford University's Cancer Institute Innovation Awards fund collaborative, cutting-edge cancer research from basic science to clinical and population studies to improve prevention, diagnosis, and treatment.
Funder: Stanford University
Due Dates: October 15, 2026: Proposal Submission Deadline
Funding Amounts: Up to $75,000 per project for a 12-month period; limited capital equipment allowed (up to $3,000).
Summary: Supports innovative, collaborative cancer research at Stanford, spanning basic, translational, clinical, and population studies.
Key Information: Only Stanford Academic Council or University Medical Line faculty may serve as PI/Co-PI; postdocs/instructors cannot apply as PI/Co-PI.
Description
The Stanford Cancer Institute Innovation Awards are designed to accelerate progress in cancer research by funding innovative projects across basic, translational, clinical, and population-based studies. The program emphasizes interdisciplinary collaboration, investigator-initiated clinical trials, and community engagement initiatives to improve cancer prevention, diagnosis, and treatment. Projects should aim to translate scientific discoveries into improved patient care and outcomes, aligning with the Stanford Cancer Institute’s mission to reduce cancer mortality and enhance patient experiences.
